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Abstract  
The expression of neuronal NO synthase (nNOS) alpha- and beta-isoforms in 
skeletal muscle is well documented but only little information is available about their 
regulation/functions. Using different mouse models, we now assessed whether the 
expression of nNOS-isoforms in muscle fibers is related to mitochondria 
content/activity and regulated by peroxisome proliferator-activated receptor gamma 
coactivator-1alpha (PGC-1alpha). Catalytic histochemistry revealed highest nNOS-
concentrations to be present in type-2 oxidative muscle fibers. Differences in 
mitochondrial density between nNOS-KO-mice and WT-littermates established by 
morphometry after transmission electron microscopy were significant in the oxidative 
portion of the tibialis anterior muscle (TA) but not in rectus femoris muscle (RF) 
indicating an nNOS-dependent mitochondrial pool in TA. Quantitative immunoblotting 
displayed the nNOS alpha-isoform to preponderate in those striated muscles of 
C57Bl/6-mice that comprise of many type-2 oxidative fibers, e.g. TA, while roughly 
even levels of the two nNOS-isoforms were expressed in those muscles that mainly 
consist of type-2 glycolytic fibers, e.g. RF. Differences in citrate synthase-activity in 
muscle homogenates between nNOS-KO-mice and WT-littermates were positively 
related to nNOS alpha-isoform levels. In transgenic-mice over-expressing muscular 
PGC-1alpha compared to WT-littermates, immunoblotting revealed a significant shift 
in nNOS-expression in favor of the alpha-isoform in six out of eight striated muscles 
(exceptions: soleus muscle and tongue) without consistent relationship to changes in 
the expression of mitochondrial markers. In summary, our study demonstrated the 
nNOS alpha-isoform expression to be related to mitochondrial content/activity and to 
be up-regulated by up-stream PGC-1alpha in striated muscles, particularly in those 
enriched with type-2 oxidative fibers implying a functional convergence of the two 
signaling systems in these fibers. 
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Abbreviations 
NO, nitric oxide; nNOS, neuronal nitric oxide synthase; PGC-1alpha, peroxisome 
proliferator-activated receptor gamma coactivator-1alpha; KO, knockout; TG, 
transgenic; CS, citrate synthase; SDH, succinate dehydrogenase; ROS, reactive 
oxygen species; NBT, nitroblue tetrazolium; TEM, transmission electron microscopy; 
TA, tibialis anterior muscle; RF, rectus femoris muscle; EDL, extensor digitorum 
longus muscle; PLNT, plantaris muscle; SOL, soleus muscle; GC, gastrocnemius 
muscle 
 
Highlights  
• Highest nNOS-levels are expressed in type-2 oxidative fibers in striated muscles 
of mice 
• Muscle nNOS-alpha isoform is positively related to differences in citrate 
synthase-activity between nNOS-KO-mice and WT-littermates 
• nNOS alpha-isoform preponderates in striated muscles with many type-2 
oxidative fibers 
• In muscles of PGC-1alpha transgenic mice, nNOS-expression is shifted in favor 
of the alpha-isoform without consistent relationship to changes in the expression of 
mitochondrial markers 
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1. Introduction 
Gaseous nitric oxide (NO) is generated by the catalytic activity of neuronal NO 
synthase (nNOS) in skeletal muscles of rodents and humans. Dimer aggregates of 
nNOS are clustered at the sarcolemma, especially in fast-twitch (type-2) oxidative 
muscle fibers of rodents [1; 2]. The fiber surface targeting of nNOS is mediated either 
indirectly via interaction with alpha-syntrophin [3] and/or other adapter proteins [4] or 
by direct binding to dystrophin [5; 6; 7] and is pivotal for its correct and integrated 
function. Accordingly, variations in the sarcolemmal anchorage of nNOS contribute to 
the etiology and progression of several distinctive muscular dystrophies [8; 9; 10].  
As a pleiotropic second messenger, NO produced by nNOS-activity influences via 
the established soluble guanylate cyclase/cGMP-signaling cascade [11] and/or S-
nitrosylation of enzymes and fibrillar proteins in skeletal muscle fibers [12]. As a 
result, several reactions of the oxidative metabolism in skeletal muscle fibers are 
modulated at different levels, e.g. to establish an intact mitochondrial phenotype [13; 
14], although the integration of nNOS action into the cell signaling network that 
controls the oxidative phenotype of muscle fibers is currently only partially 
understood [15]. Because nNOS exerts also a positive effect on sarcomeric 
assembly in vitro [16], it has been speculated that the nNOS/NO system influences 
hypertrophy [17] and age-related sarcopenia [18]. Other studies revealed that nNOS-
generated NO also acts as a paracrine signaling molecule that impacts the 
microvascular system in skeletal muscle [19; 20]. Taken together, nNOS may 
influence simultaneously the phenotype and function of both the muscle fibers and 
the microcirculation in skeletal muscle at several levels and is thus an enzyme that is 
well positioned to modulate the interplay between the two tissues. This integrative 
character of the nNOS/NO-system in skeletal muscle is especially relevant for the 
higher requirement of oxygen and substrates during endurance exercise [21].  
Studies using nNOS-KO mice [22] and nNOS-overexpressing transgenic mice [23] 
have previously shown that an alteration of nNOS expression levels in skeletal 
muscle is accompanied by a change in the availability of superoxide and, 
subsequently, hydrogen peroxide (SOD-1 dependent) and/or peroxynitrite. Thus, 
nNOS participates in the scavenging of reactive oxygen species (ROS), which could 
damage proteins and lipids within the skeletal muscle fibers [24]. Because ROS also 
exert important cell signaling functions, the nNOS/NO system may act not only as 
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direct but also indirect (by depletion of ROS) modulator of cell signaling processes 
[25].  
Various isoforms of nNOS are expressed in skeletal muscle. Among the nine nNOS-
variants with the alternatively spliced non-translated exon-1 being present in humans 
[26], only four (1b, 1c, 1g and 1h) mRNA-variants were likewise found in the mouse 
[3]. At the protein level, two major nNOS-isoforms have been identified in human and 
mouse striated muscles: alpha (160 kDa) and beta-isoforms (140 kDa) of nNOS that 
differ in the presence/absence of a 237 amino acid long stretch at the N-terminus 
which is generated by alternative splicing of exon-2 [3]. Both alpha- and beta-variants 
of nNOS might display a 102-bp long nucleotide stretch (designated exon-mu) 
subjected to alternative splicing between exons 16 and 17 [27].  
The additional exon-2 of the nNOS alpha-isoform contains a PDZ domain that 
mediates the fiber surface targeting [3]. The physiology of the nNOS alpha-isoform is 
well studied [15]: due to its sarcolemmal anchorage this enzyme or rather its reaction 
product NO impacts the metabolic demands of the striated musculature, as 
mentioned above. In contrast, the beta-variant of nNOS has not been thoroughly 
characterized so far - a circumstance that reflects the non-availability of a specific 
antibody against this nNOS-isoform.  
There is only few and partly conflicting information available about distinctive 
expression patterns, biochemical properties and functional relevance in skeletal 
muscle of these nNOS-variants. Recombinant alpha and beta-isoforms of nNOS 
exhibit NOS activity with similar catalytic properties in homogenates of transfected 
COS-cells [3]. Percival et al. have attributed a Golgi apparatus-associated 
localization in muscle fibers of the nNOS beta-isoform and a role in force 
maintenance during and after exercise in mice [28]. However, this interpretation of 
the data of this is largely speculative, since no information regarding the expression 
of the beta-isoform was furnished at either the mRNA or protein level. Using a set of 
antibodies that recognize either only the alpha-isoform or simultaneously both nNOS-
variants, we have found evidence that both nNOS-isoforms are associated at the 
sarcolemma [29] possibly acting as a heterodimer. The reason for the differences in 
the determination of nNOS isoform localization in skeletal muscle fibers [28; 29] 
remains to be clarified. 
The incomplete characterization of the nNOS action within the oxidative metabolism 
as well as the fragmented knowledge about the biochemistry of the nNOS-variants in 
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skeletal muscles provided so far has encouraged us to speculate that the 
appearance of one or both nNOS-isoforms is/are related to the mitochondrial 
phenotype of this tissue. To address this hypothesis, we first systematically 
monitored the expression patterns of the two major isoforms in several striated 
muscles of mice with different metabolic profiles to relate these data to the 
mitochondrial density in these tissues. In order to obtain insights into the regulation of 
the nNOS isoform-specific expression patterns, we have also characterized the 
interaction of the alpha- and beta-isoforms of nNOS with PGC-1alpha, a master 
regulator gene of mitochondrial biogenesis [30; 31]. Our analysis reveals that the 
expression of the nNOS alpha-isoform is positively related to mitochondria density 
and PGC-1alpha expression in striated muscles with many type-2 fibers, suggesting 
a close connection between the nNOS alpha-isoform and the oxidative capacity in 
type-2-rich skeletal muscles, which has hitherto not been described. 
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2. Materials and methods 
2.1  Animals 
Histochemical, electron microscopy and biochemical studies were performed on 
striated muscles from male C57/BL6 mice in the age of nine weeks (Charles River, 
Sulzfeld, Germany). 
The nNOS-knockout (KO) strain of mice with C57BL/6-background utilized in this 
study was originally generated by the recombinant replacement of exon-2 of the 
nNOS-gene with a neomycin cassette [32]. We purchased a founder generation of 
these mice from Jackson Laboratories, Bar Harbor, ME, USA. By inbreeding of 
heterozygous (C57BL/6-WT x nNOS-KO) mice (F1-offsprings), seven litters were 
obtained (F2-offsprings) which were subjected to genotyping using DNA from 
biopsies of the tail tips (Supplementary Fig. 1). The homozygous male mice of 
these litters were euthanized at the age of 16-weeks to collect the skeletal muscles 
for molecular and structural analyses [33].  
The keeping of the muscle-specific PGC-1alpha (PGC-1alpha) transgenic (TG) mice 
and their WT littermates was previously described [34].  
All mice were maintained in conventional animal facilities in Bern or Zurich, 
respectively, with a fixed 12-h light/dark cycle on a commercial pelleted chow diet 
with free access to tap water. At sacrifice, mice were anesthetized with a 
ketamine/xylazine (100 mg*kg-1/5 mg*kg-1) cocktail via IP injection. All mice were 
treated and sacrificed in accordance with the approvals published by the Cantonal 
Committee on Animal Welfare [Amt für Landwirtschaft und Natur des Kantons Bern 
(51/08 and 27/12)] and the Universities of Bern and Zurich. 
 
2.2 Muscles 
For the analyses, the following striated muscles of the nNOS-KO mice and their WT 
littermates as well as PGC-1alpha-TG mice and their WT littermates were used: 
tibialis anterior (TA), extensor digitorum longus (EDL), rectus femoris (RF) of the 
quadriceps femoris, plantaris (PLNT), soleus (SOL), gastrocnemius (GC) - caput 
lateralis (lat) and caput medialis (med) and the tongue.  
 
2.3 Histochemistry 
For succinate dehydrogenase (SDH) histochemistry, unfixed cryostat sections of 10 
µm thickness were incubated in a moist chamber with SDH medium (1.5 mg/ml 
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sodium-succinate, 0.25 mg/ml nitroblue tetrazolium (NBT) salt in 0.1 M phosphate 
buffer, pH 7.2) at 37°C for 30 min, then washed with deionized water and finally 
cover-slipped in glycerol gelatin.  
NADPH diaphorase histochemistry specific for nNOS was carried out using 1 M urea 
in the incubation buffer as previously reported [35]. Quantification of SDH and nNOS-
diaphorase histochemical activity in individual muscle fibers was performed by image 
analysis as previously described in detail [2].  
 
2.4 Electron microscopy and morphometry 
TA and RF muscles were subjected to transmission electron microscopy (TEM) 
analysis. Therefore, TA muscle was longitudinally sliced to obtain the oxidative 
proportion (originally adjacent to the tibia), which was processed for TEM analysis. 
Ultrathin sections (50-60 nm in thickness) of Epon resin blocks of the muscles were 
prepared as previously described [36]. The inspection of the Epon blocks was carried 
out using a transmission electron microscope (Morgagni M268; FEI, Brno, Czech 
Republic). Morphometric estimation of the mean volume density (Vv) of mitochondria 
on 20 randomly depicted micrographs taken of each of the ultrathin sections, at a 
magnification of x24,000, were also carried out using established methods as 
previously described [36]. 
 
2.5 Immunoblotting 
The muscles were homogenized in solubilization buffer (1% (w/v) Triton-X 100 and 1 
mM phenylmethylsulfonyl fluoride in PBS-HCl, pH 7.4), as previously described [33]. 
Immunoblotting was performed using 50 µg of protein from skeletal muscles. The blot 
matrices were incubated with the following primary anti-nNOS antibody in final 0.1 
µg/ml concentration diluted in washing buffer (0.1% (w/v) Tween 20 in PBS, pH 7.4) 
overnight at 4°C: N-7280 (Sigma-Aldrich, Buchs, Switzerland), which specifically 
identifies amino acids 1409-1429 in the C-terminal region of the rat and mouse 
primary structure or with the mitochondria-specific OXPHOS Rodent WB Antibody 
Cocktail (ab110413; Abcam, Cambridge, UK), diluted 1:1.000 in washing buffer. 
The immunoblots were developed by enhanced chemiluminescence (GE Healthcare 
Life Sciences, Glattbrugg, Switzerland). Ponceau S-staining of the blot matrices was 
conducted for the normalization of the loading required for the densitometric 
quantification [33]. 
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2.6 Citrate synthase activity assay  
Approximately 10 mg of the muscles were homogenized in 500 ml of 100 mM Tris-
buffered saline, pH 8.3 (TBS) and 0.1% Triton X-100 at 4°C using a Polytron 
ultraturrax PT 1200 E (Kinematica, Luzern, Switzerland). Subsequently, the lysates 
were centrifuged at 14.000 rpm for 5 min at 4°C to subject aliquots of the 
supernatants to the CS activity assay and BCA protein assay. CS activity was 
determined spectrophotometrically at 30°C by measuring the appearance of 
mercaptide ion by acetyl-CoA deacylase activity according to the protocol described 
previously in detail [37]. 
 
2.7 Nitrate/nitrite fluorometric assay 
The nitrate/nitrite fluorometric assay (780051) from Cayman (Ann Arbor, MI, USA) 
was used as indirect measure for NO production. Therefore, approximately one third 
of a RF muscle per mouse was homogenized in 5 ml PBS, pH 7.4 at 4°C. After 
quantification of the protein concentration in aliquots, NOS activity was initiated by 
addition of the cofactor mixture to 1 mg of homogenate protein at RT and stopped 
after 15 min by centrifugation through ultrafiltration tubes (UFC703008, Centricon 
Plus-70, Merck, Darmstadt, Germany). Aliquots of the supernatants collected at 
initiation and termination of the reaction as well as nitrate standards were subjected 
in duplicates to the nitrate/nitrite fluorometric assay according to the instructions of 
the manufacturer. The extinction of the samples was recorded at an excitation 
wavelength of 360-365 nm and an emission wavelength of 430 nm in a SpectraMax 
190 Microplate Reader (Molecular Devices, Sunnyvale, CA, USA) and used to 
calculate the rates of nitrate/nitrite production per time unit and mg of homogenate 
protein. 
 
2.8 Data analysis and statistics 
All numerical data were expressed as mean values together with the standard 
deviation. Parameters pertaining to the structural and molecular analyses were 
compared using a paired Student’s t-test. Pearson's correlation was calculated to 
assess significance of relationship. The significance level was set at P≤0.05.  
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3 Results 
3.1 Relationship of nNOS and mitochondria in skeletal muscles  
For assessment of the nNOS/mitochondria relationship at the muscle fiber level, we 
performed nNOS-specific diaphorase and succinate dehydrogenase (SDH; 
mitochondrial marker) catalytic histochemistry on serial sections of the tibialis anterior 
(TA) muscle, which is a skeletal muscle that is almost exclusively composed of type-
2 muscle fibers [38]. As shown in Fig 1A, nNOS-specific diaphorase activity was 
exclusively located at the sarcolemma, whereas SDH activity was present inside the 
muscle fibers (Fig 1B). In both histochemical reactions, the end product formazan 
was not uniformly distributed within the muscle: the smaller skeletal muscle fibers 
contained high nNOS and SDH activities, while the larger ones showed only slight 
formazan generation. As exemplarily displayed for one TA muscle (Fig 1D), 
regression analysis with both catalytic histochemistry data sets revealed the 
expression of nNOS to be significantly (P≤0.05) related to the SDH-defined oxidative 
capacity at the muscle fiber level.  
To extend the investigation on nNOS/mitochondria relationship to the total muscle 
level, the ultrastructural phenotypes of two exemplary striated muscles were 
compared in nNOS-KO mice and WT mice (Fig 2A). When the compartmental 
composition of the skeletal muscle fibers in the oxidative portion of the TA muscle 
(rich in type-2 oxidative fibers) was assessed by morphometry, significantly less (-
9.6%; P≤0.05) mitochondria volume density was found in nNOS-KO mice than in WT 
mice (Fig 2B). While the intrafibrillar pool of mitochondria was significantly lower (-
9.9%; P≤0.05), the subsarcolemmal pool only tended to be reduced (-5.7%; P=0.08) 
in the nNOS-KO strain compared to the WT mice. In contrast, the morphometric 
analysis of the rectus femoris (RF) muscle (rich in glycolytic type-2 fibers) revealed 
the mitochondrial volume density to only non-significantly differ (+6.1%; P>0.05) 
between the two mouse strains (Fig 2C). These data indicate that the manifestation 
of the nNOS/NO-system in skeletal muscle of WT mice has a promotional effect on 
mitochondrial density in oxidative TA muscle but not glycolytic RF muscle.  
The expression patterns of nNOS in murine striated muscles were assessed by 
quantitative immunoblotting on detergent extracts of eight striated muscles (seven 
skeletal muscles of the hind limb and the tongue) from C57Bl/6-mice. As shown in 
Fig 3A, nNOS was consistently displayed in all muscle extracts as a double band 
with sizes of 160-kDa (alpha-isoform) and 140-kDa (beta-isoform). Although identical 
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amounts of protein were loaded on the gels, the intensities of the nNOS-
immunoreactive bands varied greatly between the muscles. Actually, densitometric 
analysis (Fig 3B) revealed highest levels of nNOS to be present in TA muscle, 
whereas moderate-high levels of nNOS (44-72% of concentration in TA) were 
expressed in RF, extensor digitorum longus (EDL), plantaris (PLNT), gastrocnemius 
(GC)-lateralis muscles and tongue. Only very low levels of nNOS were displayed in 
GC-medialis (11% of concentration in TA) and soleus (SOL; 4% of concentration in 
TA) muscles as anticipated, since both muscles consist to a large extent of nNOS-
poor, type-1 muscle fibers.  
 
3.2 Relationship of nNOS-isoforms and mitochondria in skeletal muscles 
The ratio of nNOS alpha- and beta-isoform expression in the immunoblots was not 
constant in the muscle samples. As assessed by densitometry (Fig 3C), nNOS 
alpha-isoform expression preponderated in most muscles (TA, EDL, GC-lat, GC-
med, SOL and tongue; 69 up to 91% versus 31 up to 9%), while roughly equal levels 
of the two nNOS-isoforms were expressed in RF (41% versus 59%) and PLNT 
muscles (56% versus 44%).  
We furthermore measured the citrate synthase (CS) activity (another mitochondrial 
marker enzyme) by an in vitro-assay in homogenates of eight striated muscles 
isolated from nNOS-KO mice and their WT littermates (Fig 4A). While the differences 
in CS activity between the two mouse strains were only non-significant (P>0.05) in 
most muscle homogenates (+6% up to -12% in nNOS-KO versus WT), the CS 
activity was significantly (P≤0.05) lower in TA (-16%) and GC-lat (-19%) muscle 
homogenates and tended to be lower (P=0.09) in the tongue homogenate (-21%) of 
the nNOS-KO mice compared to the WT mice.  
When we performed regression analysis with the data sets of CS activities in muscle 
homogenates (shown in Fig 4A) and the quantitative nNOS isoform expression in the 
muscles of the WT mice determined by immunoblotting (shown in Fig 3C and 3D), 
we found a significant (r=0.73; P≤0.05) positive relation between the nNOS alpha-
isoform expression levels and the differences in CS activities between WT mice and 
nNOS-KO mice (Fig 4B). Correspondingly, the nNOS beta-isoform expression levels 
and the differences in CS activities were negatively related (P≤0.05; data not shown). 
All other regression analyses (particularly those with the absolute CS activities from 
the WT mice) yielded only non-significant relationships between nNOS expression 
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and mitochondrial density (P>0.05; data not shown) particularly due to inclusion of 
the SOL and GC-med values, which consist mainly of oxidative type-1 fibers lacking 
substantial nNOS-expression [1]. These findings indicate that a pool of mitochondria 
exists in murine skeletal muscles with many type-2 fibers, which is related to the ratio 
of the nNOS alpha-isoform-to-beta-isoform expression in the muscle.  
 
3.3 Expression levels of nNOS isoforms in muscles of PGC-1alpha-TG mice 
The statistical relationship between nNOS alpha-isoform expression and 
mitochondrial density/activity in type-2 fibers encouraged us to clarify whether PGC-
1alpha (established transcriptional co-activator of mitochondriogenesis) influences 
the nNOS isoform expression patterns. Therefore, we analyzed detergent extracts of 
striated muscles from transgenic mice over-expressing PGC-1alpha (PGC-1alpha-
TG mice) and their WT littermates by means of quantitative immunoblotting with anti-
nNOS antibodies. In a preliminary experiment, we found the nitrite production rates in 
RF muscle homogenates, in which nNOS alpha- and beta-isoforms occur in an 
approximately balanced relationship, to differ only non-significantly (9%; P>0.05) 
between the two mouse strains suggesting that the up-regulation of PGC-1alpha 
does not impact the total NOS activity in this muscle (Fig. 5A).  
When we assessed the nNOS isoform-composition in detergent extracts of eight 
striated muscles by quantitative immunoblotting, we observed a distinctive shift in the 
expression patterns of the nNOS-isoforms in the PGC-1alpha-TG mice compared to 
their WT-littermates: in most striated muscles, the concentration of the alpha-isoform 
was increased, while the levels of the beta-isoform were simultaneously decreased 
(Supplementary Figs. 2 and 3). This effect was most pronounced in the RF muscle 
(Fig 5B). Densitometry revealed significantly (P≤0.05) higher levels of the nNOS 
alpha-isoform and simultaneously significantly (P≤0.05) lower levels of the beta-
isoform to be expressed in six muscles from PGC-1alpha TG mice compared to WT 
mice (Fig 5C). In contrast, the distribution of the nNOS alpha- and beta-isoforms 
differed only non-significantly (P>0.05) between the two mouse strains in the SOL 
and the tongue. Interestingly, the expression levels of total nNOS were inconsistent 
in the striated muscles of PGC-1alpha TG mice compared to WT mice (Fig 5D): 
while in RF, GC-med, SOL and tongue similar nNOS expression levels were 
displayed in the two mouse strains, significantly lower levels of total nNOS were 
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found in the other five skeletal muscles of PGC-1alpha TG mice (TA, EDL, GC-lat, 
PLNT, SOL). 
In order to assess whether the shift of nNOS-isoform expression in muscle extracts 
of PGC-1alpha TG mice is actually related to the PGC-1alpha-dependent increase in 
mitochondrial density, we performed immunoblotting on the detergent extracts of the 
different striated muscles with the mitochondria-specific OXPHOS antibody cocktail. 
Densitometric analysis of the blot matrices revealed that the levels of the 
mitochondrial proteins were higher in six out of the eight striated muscles of the 
PGC-1alpha TG mice compared to WT mice (Supplementary Fig. 4 and Fig 6A,B). 
The levels of mitochondrial ATP5A, quantified as a representative example (Fig 6C), 
differed only non-significantly between the two mouse strains in the soleus muscle 
and in the tongue, which concurrently exhibited a likewise non-significant shift in the 
expression of the nNOS isoforms. Accordingly, significant up-regulated ATP5A levels 
in RF, EDL and TA muscles of PGC-1alpha TG mice were accompanied by 
significant changes in the nNOS alpha/beta-isoform relationship. However, there 
were also striking deviations from this co-regulated relationship: GC-lat, GC-med and 
PLNT muscles exhibited non-significant ATP5A increases in combination with 
significant nNOS isoform-shifts, suggesting that the increases in mitochondrial 
density are only inconsistently associated with the altered nNOS-isoform expression 
patterns in striated muscles of PGC-1alpha TG mice.
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4 Discussion 
This paper addresses the relationship between nNOS isoforms, mitochondrial 
density/activity as well as PGC1alpha expression in murine striated muscles. Our 
investigation resulted in four main findings: 1. nNOS was enriched in striated muscles 
with a high proportion of type-2 oxidative fibers, 2. differences in mitochondrial 
density/activity between nNOS-KO mice and their WT littermates were more 
pronounced in type-2 oxidative than in glycolytic striated muscles, 3. the expression 
levels of the nNOS alpha-isoform in striated muscles were positively related to the 
differences in citrate synthase (CS) activity between nNOS-KO mice and their WT 
littermates and 4. the isoform expression pattern of nNOS was shifted in favor of the 
alpha-isoform and at the expense of the beta-isoform in striated muscles of 
transgenic mice over-expressing PGC-1alpha. 
 
4.1 Enrichment of nNOS in muscles with a many type-2 oxidative fibers 
Our quantitative immunoblot analysis revealed nNOS to be inconsistently distributed 
in the striated musculature of C57/Bl6-mice. Lowest levels of nNOS were found in 
muscles with a high proportion of type-1 muscle fibers (e.g. SOL, GC-med [38]), 
which is in accordance to the observation that only low nNOS concentrations are 
expressed in this fiber type in murine striated muscles [1]. In contrast, high levels of 
nNOS expression were confined to skeletal muscles with a high proportion of 
oxidative type-2 fibers, e.g. to TA muscle which consists of 40% of type-2d/x and 
type-2a fibers [38]. The single fiber analysis by catalytic histochemistry on serial 
sections of the TA muscle confirmed this distribution of nNOS: nNOS-specific 
diaphorase activity was enriched in type-2 oxidative fibers, Thus, the appearance of 
nNOS in skeletal muscles of mice resembles that of rats, in which nNOS is enriched 
in fast-twitch (type-2) oxidative fibers [2], while the enzyme is more evenly distributed 
throughout all fiber types (at least) in human vastus lateralis muscle [39; 40].  
 
4.2 Mitochondrial density/activity in nNOS-KO mice and WT littermates 
Highest CS activity levels were found in homogenates of GC-med muscle, while 
significantly lower CS activities were evidenced in RF and GC-lat muscles of both 
mouse strains. Strikingly, the differences in CS activities between the nNOS-KO mice 
and their WT littermates were likewise inconsistent within the muscles: pronounced 
differences in CS activities between the two mouse strains were found in TA and GC-
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lat muscles, while only minor differences were present in RF muscle. We understand 
such differences in CS activities between the nNOS-KO mice and their WT 
littermates as quantitative indicators for a pool of mitochondria that depends on the 
manifestation of nNOS. It is striking that striated muscles with such a large nNOS-
dependent mitochondrial pool, e.g. TA and GC-lat muscles, are those that consist to 
a greater extent of type-2 oxidative fiber types [38; 41; 42; 43]. 
The mitochondrial content of skeletal muscles in nNOS-KO mice and WT mice has 
previously been assessed several times. Morphometry after EM analysis performed 
by Schild and colleagues revealed a trend towards reduced mitochondria density in 
the GC muscle of nNOS-KO mice compared to WT mice, although they 
simultaneously observed non-significantly higher CS levels determined in 
immunoblots and significantly elevated CS activity [44]. Wadley and colleagues found 
significantly higher mRNA levels of mitochondria-associated marker genes (NRFs, 
mtTFA) in the EDL muscle (with a similar muscle fiber composition as TA) but not in 
the SOL muscles of nNOS-KO mice than in those of WT mice [13]. At the same time, 
CS activities in the EDL were not significantly higher in the nNOS-KO mice compared 
to the WT mice [13]. It has furthermore been reported that the mitochondrial DNA 
levels in TA muscles do not significantly differ between nNOS-KO and WT mice [14] 
although the graph presented in the paper shows a clear trend for lower 
mitochondrial DNA levels in the nNOS-KO strain. Taken together, the previous 
publications on this topic do not draw a consistent picture of the quantitative 
incidence of mitochondria in skeletal muscles of nNOS-KO mice compared to WT 
mice. It seems possible that specific bias of the indirect methods that were applied to 
determine the mitochondria content in these studies are (at least partially) 
responsible for the inconsistency of the results.  
To overcome this methodological drawback, we performed morphometry after EM 
analysis, which is considered as the ‘gold standard’ method for the determination of 
the compartmental composition in tissues due to the direct visualization and 
quantification of the cellular structures [45]. In this investigation, we found the 
mitochondrial volume density in the oxidative proportion of the TA muscle to be 
significantly lower in nNOS-KO mice than in their WT littermates. In contrast, when 
we subjected the non-oxidative RF muscle to the same morphometric protocol, the 
values for mitochondrial volume density differed only non-significantly between the 
two mouse strains. These findings are in line to the conclusion drawn on the basis of 
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the CS activity assay that an nNOS-dependent mitochondrial pool exists in type-2 
oxidative skeletal muscle fibers. 
Remarkably, on the electron micrographs we have never observed myopathic 
structural changes of the mitochondrial phenotype in the skeletal muscles of the 
nNOS-KO mice, which had been previously reported [14; 28]. The reasons for these 
contradictory findings are unknown. 
 
4.3 nNOS alpha-isoform is enriched in oxidative striated muscles of mice 
Our immunoblotting investigation is the first one in which the relation between 160-
kDa alpha- and 140-kDa beta-isoforms of nNOS was systematically quantified in 
murine striated muscles. Highest concentrations of the alpha-isoform of nNOS were 
seen in TA, while almost equal levels of alpha- and beta-isoforms were present in RF 
and PLNT muscles of mice. All other muscles exhibited an nNOS alpha-isoform/beta-
isoform ratio between these two outsider values. As mentioned above, TA muscle is 
composed of a high proportion of fast-twitch oxidative 2d/x and 2a fibers, while RF 
and PLNT muscles consist almost entirely of type-2b glycolytic fibers [38]. We 
therefore suspect that the alpha-isoform of nNOS is enriched in type-2 oxidative 
fibers (type-2d/x and type-2a), while type-2b fibers contain equivalent levels of nNOS 
alpha- and beta-isoforms. This hypothesis has to be confirmed by other approaches, 
e.g. fiber typing in combination with anti-nNOS immunohistochemistry, which 
however is a difficult task because a specific antibody against the nNOS beta-isoform 
is not available.  
When we performed regression analysis with the data sets from the CS activity assay 
and the quantitative nNOS-immunoblotting we found a significant positive relation 
between the differences in mitochondrial density of nNOS-KO mice and their WT 
littermates and the expression levels of the nNOS alpha-isoform. The statistical link 
between the nNOS alpha-isoform expression levels and the CS-dependent activity 
does however not allow concluding that this nNOS-variant is the enzyme that 
specifically controls the extent of the nNOS-dependent mitochondrial pool in murine 
skeletal muscles with a high proportion of oxidative fibers. In fact, additional 
investigations must be undertaken in order to demonstrate such a potential functional 
relationship between nNOS alpha-isoform and mitochondrial density. 
Interestingly, it has recently been shown that the nNOS alpha-isoform but not the 
beta-isoform is translocated to the nucleus in C2C12 cells via an alpha1-syntrophin 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
17
binding leading to S-nitrosylation of the transcriptions factor CREB and subsequent 
mitochondriogenesis owing to the up-regulation of mitochondrial genes such as 
TFAM and MtCO1 [46]. This sequence of cellular events could be (at least be part of) 
the molecular cascade(s) that elicits the nNOS alpha-isoform-dependent higher 
mitochondrial density in vivo, as described here. 
This investigation was performed on striated muscles of resting mice. It is possible 
that the statistical relations described here (e.g. between nNOS alpha-isoform and 
mitochondrial activity in type-2 fibers) are altered during/after endurance exercise 
when both nNOS levels/activities [46] and mitochondrial density are increased. 
Further research has to be done to clarify this issue. 
 
4.4 Shift in favor of the nNOS alpha-isoform in PGC-1alpha transgenic mice 
Emanating from the observation nNOS alpha-isoform is related to the mitochondrial 
density in murine skeletal muscle, we assessed whether the expression patterns of 
the nNOS variants are regulated in relation to genes that control the mitochondrial 
density. For this task, we focused to study the relation of nNOS to PGC-1alpha, 
which belongs to a family of established (co)factors that drive the quantity of 
mitochondria in many tissues, including skeletal muscle [30; 31]. This decision was 
based on the observation that even type-2 fibers express low levels of PGC-1alpha in 
WT mice [30], and, thus, exhibit the potential to adapt to the strong increase in PGC-
1alpha expression induced by the genetic manipulation of the TG mice.  
In detergent extracts of striated muscles with many type-2 oxidative fibers, we 
observed a significant shift in the expression patterns of the nNOS isoforms in favor 
of the alpha-isoform and at the expense of the beta-isoform in PGC-1alpha TG mice 
compared to their WT littermates. These findings suggest that PGC-1alpha has an 
up-stream impact on the regulation of the nNOS isoforms expression patterns by 
increasing the levels of the alpha-isoform in combination with the simultaneous 
down-regulation of the beta-isoform in these muscles. Interestingly, the nitrite 
production rates in VL muscle extracts of PGC-1alpha TG mice and WT mice were 
alike indicating that the nNOS alpha- and beta-isoforms exhibit similar catalytic NOS 
activities. This conclusion is in accordance to the findings obtained with the 
recombinant proteins [3]. 
As signaling enzyme, nNOS is involved in the regulation of many physiological 
processes in skeletal muscle fibers [15]. The nNOS/NO system lowers in an 
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autocrine fashion the contraction force [1], contributes to glucose uptake during 
contraction/exercise in a complex pattern [47; 48; 49], exhibits a positive allosteric 
effect on phosofructokinase-1 activity [50] and impacts the lipid metabolism [44] in 
skeletal muscle fibers. Furthermore, nNOS has likewise a positive influence on the 
capillary density, which is reduced in nNOS-KO mice [33]. Common consequence of 
this wide spectrum of functions is the increase in glucose availability in the skeletal 
fibers either by accelerating anaplerotic reactions or inhibition of carbohydrate 
oxidation. 
PGC-1alpha has likewise a modulatory effect on a broad range of metabolic 
processes in skeletal muscles. Originally identified as a master co-regulating factor of 
mitochondriogenesis via interaction with multiple transcription factors, it was 
subsequently shown that PGC-1alpha also modulates numerous other metabolic 
processes, which prevent glucose consumption and promote lipid oxidation [34]. It is 
also established that PGC-1alpha increases capillary density and angiogenesis in 
skeletal muscle [51]. Thus, from a biological point-of-view it is conceivable that nNOS 
and PGC-1alpha may functionally converge in type-2 oxidative muscle fibers: cell 
signaling processes of both proteins merge e.g. into an increase of the intrafibrar 
glucose availability. Because the increases in mitochondrial density were only 
inconsistently associated with the altered nNOS-isoform expression patterns in 
striated muscles of PGC-1alpha TG mice we suggest that the two proteins are not 
obligatory linked to induce the biogenesis of new mitochondria. 
The findings of this study imply that PGC-1alpha is located up-stream of nNOS within 
the signaling chain inside type-2 oxidative skeletal muscle fibers to induce the shift in 
nNOS expression in favor of the nNOS alpha-isoform. Other studies revealed that 
PGC-1alpha might also be situated down-stream of nNOS action: NO is capable to 
increase PGC-1alpha expression to up-regulate mitochondrial biogenesis in many 
cells and tissues [52], including L6 myotubes [53].  
Baldelli and colleagues [54] have recently proposed that both nNOS and PGC-1alpha 
are integrative linkers within a molecular network that commonly influences the 
metabolism in muscle cells/fibers. Our in vivo findings specify this hypothesis 
demonstrating that a nNOS-dependent pool of mitochondria is established in type-2 
oxidative skeletal muscle fibers related to the nNOS alpha-isoform, which may be 
considerably up-regulated by PGC-1alpha action. Therefore, the interaction between 
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nNOS and PGC-1alpha appears to be nNOS isoform-specific and seems to involve 
the mutual regulation of both proteins in a fiber type-specific manner. 
 
5. Conclusions 
Combination of the conclusions on our main findings (1. preponderance of nNOS in 
type-2 oxidative skeletal muscle fibers, 2. existence of a nNOS-dependent 
mitochondrial pool in type-2 oxidative skeletal muscle fibers, 3. correlation between 
nNOS-alpha isoform and this nNOS-dependent mitochondrial pool in type-2 oxidative 
fibers and 4. up-regulation of the nNOS-alpha isoform in striated muscles of PGC-
1alpha TG mice) leads us to hypothesize that the two signaling systems functionally 
converge in type-2 oxidative skeletal muscle fibers of mice. 
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Figure legends 
 
Fig 1: Catalytic histochemistry to determine the statistical relationship between 
nNOS-specific diaphorase and succinate dehydrogenase activities at the 
muscle fiber level. A,B: Representative serial sections of the TA muscle subjected 
to catalytic histochemistry to monitor the activity of nNOS-specific diaphorase (A) and 
mitochondria-related succinate dehydrogenase (SDH; B). Note that the larger 
skeletal muscle fibers (asterisks) contain simultaneously less nNOS-diaphorase and 
SDH activities than smaller ones. C: Negative control for nNOS-specific diaphorase 
reaction shown in A. D: Linear regression analysis revealing a significant positive 
relation between nNOS-specific diaphorase and SDH activities. The plot mirrors the 
densitometric values in skeletal muscle fibers from the oxidative portion of TA 
muscle. Shown is the Pearson product-moment correlation coefficient (r) together 
with its probability (P). Bear in mind that the TA muscle of mice is almost exclusively 
composed of type-2 skeletal muscle fibers.  
 
Fig 2:  Morphometry after transmission electron microscopy to estimate 
mitochondria volume density in tibialis anterior (TA) and rectus femoris (RF) 
muscles of nNOS-KO mice and their WT littermates. A: Representative electron 
micrographs of TA muscle from an nNOS-KO mouse and a WT littermate each 
depicting a cross-sectioned capillary profile surrounded by profiles of three skeletal 
muscle fibers. Note the subsarcolemmal and the myofibrillar pool of mitochondria 
manifested in all muscle fibers. B, C: Morphometric quantification of the total 
mitochondrial volume density in skeletal muscle fibers as well as its allocation among 
the subsarcolemmal and intrafibrillar pools in TA muscle (B) and RF muscle (C) of 
nNOS-KO mice and WT littermates. Mean values ± SD, n=5 for both mouse strains. 
Significance level: *: P ≤ 0.05. 
 
Fig 3: Inconsistent expression of nNOS in striated muscles of C57/Bl6 mice. A: 
50 µg of protein from detergent solubilsates of eight striated muscles taken from 
C57BL/6-mice were subjected to immunoblot analysis with a polyclonal anti-nNOS 
antibody (anti-C-terminus). B: The blot matrices were stained with Ponceau Red after 
immunoblotting for loading control. C: The nNOS-immunoreactive bands in the 
muscle solubilsates were densitometrically quantified and normalized to protein 
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loading assessed by Ponceau S-staining in order to depict the nNOS level in each 
muscle. The concentration of nNOS bands in TA muscle was set as 100%. Mean 
values ± SD, n=4. D: The expression ratio between the 160-kDa (alpha)- and 140-
kDa (beta)-isoforms of nNOS in striated muscles of mice, as determined by 
densitometry of the nNOS-bands after immunoblotting. Mean values ± SD, n=4. 
 
Fig 4:  Citrate synthase assay to establish the statistical relationship between 
alpha-isoform expression and mitochondrial density in striated muscle. A: 
Citrate synthase (CS) activity was assessed in homogenates of eight striated 
muscles from nNOS-KO mice and their WT littermates. Mean values ± SD, n=3 
triplicates for both strains. *: P ≤ 0.05. B: Linear regression analysis revealing the 
difference in CS activity between WT mice and nNOS-KO mice (data from Fig 4A) to 
be significantly positive related to the relative nNOS alpha-isoform levels in striated 
muscles of WT mice (data from Fig 1C and 1D). Shown is the Pearson product-
moment correlation coefficient (r) together with its probability (P). 
 
Fig 5:  Shift of the nNOS-isoform expression patterns in striated muscles of 
PGC-1alpha-transgenic (TG) mice in comparison to WT mice. A: The nitrite 
production rates, which correspond to NOS activity, were assessed in RF muscle 
homogenates of PGC-1alpha-TG mice and their WT littermates by a fluorometric 
assay based on the nitrosylation of 2,3-diaminonaphthalene (DAN) to yield 
fluorescent 2,3-naphthotriazole. Mean values ± SD, n=6 duplicates for both strains. 
B: 50 µg of protein from solubilsates of RF muscle from PGC-1alpha-TG mice and 
WT mice were subjected to immunoblot analysis with a polyclonal anti-nNOS 
antibody. Note the increased levels of the nNOS alpha-isoform (160-kDa) relative to 
those of the beta-isoform (140-kDa) in the PGC-1alpha-TG mice compared to WT 
mice. D: Relation of the nNOS alpha- and beta-isoforms in detergent extracts of eight 
striated muscles from PGC-1alpha-tg mice and WT mice. The total nNOS 
concentration in each muscle was set as 100%. Mean values ± SD, n=6 for each 
group (with exceptions, see Supplementary Fig. 2). E: Densitometric quantification of 
total nNOS-immunoreactivity in detergent extracts of eight striated muscles from 
PGC-1alpha-tg mice and WT mice. The mean nNOS concentration in the WT mice 
was set as 100%. Mean values ± SD, n=6 for each group (with exceptions, see 
Supplementary Fig. 3).  
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Fig. 6: The shift in nNOS-isoform expression patterns is inconsistently related 
to the increase in mitochondria protein levels in muscle extracts of PGC-1alpha 
TG mice compared to WT littermates. Detergent extracts of the tongue (A), the 
rectus femoris (RF) muscle (B) and six other striated muscles (Supplementary Fig 4) 
were subjected to immunoblotting with the mitochondria-specific OXPHOS antibody 
cocktail accounting for ATP5A of complex (C) 5 (55 kDa), SDHB of C2 (30 kDa) and 
NDUFB8 of C1 (20 kDa). * denote samples which contained higher (P<0.05) protein 
levels in the detergent extracts of the PGC-1alpha-TG mice than the WT mice. C: 
The changes in expression levels of mitochondrial ATP5A, quantified as 
representative example by densitometry of the immunoblot bands, were related to 
the shift in the expression of the nNOS-isoforms in the eight striated muscles of the 
PGC-1alpha-TG mice versus those of the WT mice.  
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Supporting information 
Supplementary Fig. 1: Genotyping to demonstrate the absence of nNOS in the 
genome of nNOS-KO mice and its presence in that of their WT littermates. 
Using primers for exon-2 of the nNOS gene, a cDNA fragment of the neomycin 
resistance gene (280 base pairs (Bp) long) was amplified, whereas the presence of 
the nNOS gene was demonstrated by the amplification of its exon-2 containing 
fragment (117 Bp long). 
 
Supplementary Figure 2: Shift of the nNOS isoform expression pattern in the 
rectus femoris muscle of PGC-1alpha transgenic (TG) mice in comparison to 
wild-type (WT) littermates (left side) and the Ponceau Red-stained blot matrices 
(right side). Note the higher expression of the alpha-isoform of nNOS (160 kDa) 
than the beta-isoform (140 kDa) in the PGC-1alpha TG mice than the WT mice. 
Shown are all immunoblots used for the densitometric analysis presented in Fig. 5C 
and 5D. Therefore, the densitometric values for nNOS-immunoreactive bands were 
normalized to the densitometric values of total protein loaded on the gels, as 
visualized by Ponceau Red-staining. 
 
Supplementary Fig. 3: Immunoblot analysis for the quantification of nNOS 
isoform expression in eight striated muscles from PGC-1alpha-TG mice and 
their WT littermates. The immunoblots were used for the densitometric 
quantification of nNOS isoform expression shown in Fig. 5d and 5e. For both strains, 
detergent extracts of six mice (1-6) were subjected to the analysis. * denote samples 
which were not included into the densitometry due to inaccurate gel loading and/or 
incorrect supply with ECL reagent during development of immunoblots. 
 
Supplementary Figure 4: Immunoblot analysis for the quantification of 
mitochondrial protein expression in six striated muscles from PGC-1alpha-TG 
mice and their WT littermates. For both strains, detergent extracts of six mice (1-6) 
were subjected to the analysis using the OXPHOS antibody cocktail accounting for 
ATP5A of complex (C) 5 (55 kDa), SDHB of C2 (30 kDa) and NDUFB8 of C1 (20 
kDa) * denote samples which contained higher (P<0.05) protein levels in the 
detergent extracts of the PGC-1alpha-TG mice than the WT mice. Please note that 
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the immunoblots with the extracts of two additional striated muscles (RF and tongue) 
are presented in Fig. 6. 
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Highlights  
• Highest nNOS-levels are expressed in type-2 oxidative fibers in striated muscles 
of mice 
• Muscle nNOS-alpha isoform is positively related to differences in citrate 
synthase-activity between nNOS-KO-mice and WT-littermates 
• nNOS alpha-isoform preponderates in striated muscles with many type-2 
oxidative fibers 
• In muscles of PGC-1alpha transgenic mice, nNOS-expression is shifted in favor 
of the alpha-isoform without consistent relationship to changes in the expression of 
mitochondrial markers 
